Advanced search
Publication Cover
Hemoglobin
international journal for hemoglobin research
Volume 42, 2018 - Issue 1
Submit an article Journal homepage
123
Views
6
CrossRef citations to date
0
Altmetric
Short Communication

Hepatocellular Carcinoma in a β-Thalassemia Intermedia Patient: Yet Another Case in the Expanding Epidemic

Hassan M. MoukhadderDepartment of Internal Medicine, American University of Beirut Medical Center, Beirut, Lebanon
,
Joseph E. RoumiDepartment of Internal Medicine, American University of Beirut Medical Center, Beirut, Lebanon
,
Rayan Bou-FakhredinDepartment of Internal Medicine, American University of Beirut Medical Center, Beirut, Lebanon
&
Ali T. TaherDepartment of Internal Medicine, American University of Beirut Medical Center, Beirut, LebanonCorrespondence[email protected]
Pages 58-60 | Received 31 Oct 2017, Accepted 10 Jan 2018, Published online: 01 Mar 2018

References

  • Mancuso A. Hepatocellular carcinoma in thalassemia: A critical review. World J Hepatol. 2010;2(5):171–174.
  • Borgna Pignatti C, Vergine G, Lombardo T, et al. Hepatocellular carcinoma in the thalassaemia syndromes. Br J Haematol. 2004;124(1):114–117.
  • Moukhadder HM, Halawi R, Cappellini MD, Taher AT. Hepatocellular carcinoma as an emerging morbidity in the thalassemia syndromes: a comprehensive review. Cancer. 2017;123(5):751–758.
  • Mancuso A. Management of hepatocellular carcinoma: enlightening the gray zones. World J Hepatol. 2013;5(6):302–310.
  • Kowdley KV. Iron, hemochromatosis, and hepatocellular carcinoma. Gastroenterology. 2004;127(5):S79–S86.
  • Nemeth E. Hepcidin in β thalassemia. Ann NY Acad Sci. 2010;1202(1):31–35.
  • Musallam KM, Cappellini MD, Taher AT. Evaluation of the 5mg/g liver iron concentration threshold and its association with morbidity in patients with β-thalassemia intermedia. Blood Cells Mol Dis. 2013;51(1):35–38.
  • Taher A, Musallam KM, El Rassi F, et al. Levels of non transferrin bound iron as an index of iron overload in patients with thalassaemia intermedia. Br J Haematol. 2009;146(5):569–572.
  • El-Serag HB, Rudolph KL. Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology. 2007;132(7):2557–2576.
  • Borgna Pignatti C, De Stefano P, Sessa F, Avato F. Hepatocellular carcinoma in thalassemia major. Med Pediatr Oncol. 1986;14(6):327–328.
  • Borgna Pignatti C, Garani MC, Forni GL, et al. Hepatocellular carcinoma in thalassaemia: an update of the Italian Registry. Br J Haematol. 2014;167(1):121–126.
  • Angelucci E, Brittenham GM, Mclaren CE, et al. Hepatic iron concentration and total body iron stores in thalassemia major. N Engl J Med. 2000;343(5):327–331.
  • Saliba AN, Musallam KM, Cappellini MD, et al. Serum ferritin values between 300 and 800 ng/mL in nontransfusion-dependent thalassemia: a probability curve to guide clinical decision making when MRI is unavailable. Am J Hematol. 2017;92(3):E35–E37.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.